CTOs on the Move

SonderMind

www.sondermind.com

 
SonderMind makes it easier for people who are searching for a mental health professional to find licensed therapists who are available for in-person or video sessions.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

SonderMind raised $27M on 04/06/2020

Similar Companies

WESTLAKE Financial Group

We support human resource departments and organizational workforces. From HR and benefits consulting services to health plan network management to benefits administration functions and processes, we support each and every aspect of a company's benefit

Salud Dorada con Medicare

Salud Dorada con Medicare is a Bayamon, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Animal Derm Clinic

Animal Dermatology Group is a veterinary dermatology specialty company with the worlds largest unified group of veterinary dermatology specialists engaged in the diagnosis and treatment of acute and chronic skin conditions in pets.

Humacyte

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.

Grunenthal

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.